Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Achillion, Vertex rally on Gilead's woes
Marketwatch
Friday, February 17, 2012 - 1:17pm
tags:
Vertex, Gilead, Achillion, GS-7977, protease inhibitors, hepatitis C
Dendreon: Overall Survival Data For Provenge From 2012 GU Poster
Seeking Alpha
Friday, February 17, 2012 - 1:15pm
tags:
Dendreon, prostate cancer, Provenge
EU suggests new approval for diabetes drug Byetta
Yahoo/AP
Friday, February 17, 2012 - 1:14pm
tags:
Europe, diabetes, Byetta, Amylin, Eli Lilly
A Hidden Reason Forest Laboratories' Future Looks Bright
Motley Fool
Friday, February 17, 2012 - 1:13pm
tags:
Forest Labs
Bristol gets U.S. subpoena on Abilify marketing
Reuters
Friday, February 17, 2012 - 1:11pm
tags:
Abilify, Bristol-Myers Squibb, depression, schizophrenia
Vivus obesity drug has safety risks-US FDA staff
Reuters
Friday, February 17, 2012 - 9:12am
tags:
Vivus, obesity, FDA, Qnexa
How the medical industry is using (and could use): Pinterest
Med City News
Friday, February 17, 2012 - 9:10am
tags:
social media, Pinterest
California Supreme Court to hear pay-for-delay case v. Bayer
Reuters
Friday, February 17, 2012 - 9:09am
tags:
California, pay-for-delay, Bayer, generics, Cipro
Microchip Implant Makes Remote-Controlled Drug Delivery Possible
Bloomberg
Friday, February 17, 2012 - 9:08am
tags:
drug delivery, microchip implants, Forteo, Eli Lilly, generics, MicroCHIPS
Novartis to Add Warnings to Rasilez Blood-Pressure Drug
Bloomberg
Friday, February 17, 2012 - 9:06am
tags:
Novartis, Rasilez, Europe, warnings, Tekturna
Gilead Suffers First Hep C Drug Setback
TheStreet.com
Friday, February 17, 2012 - 9:05am
tags:
Gilead, hepatitis C, GS-7977
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
TheStreet.com
Friday, February 17, 2012 - 9:05am
tags:
Vivus, Chelsea Therapeutics, Keryx, Biocryst, Exelixis, BioSante
Alexza Prices $22 Million Public Offering
Yahoo
Friday, February 17, 2012 - 9:03am
tags:
Alexza, stock offering
Avanir Pharmaceuticals: Limelight On The Horizon
Seeking Alpha
Friday, February 17, 2012 - 9:02am
tags:
Avanir, Nuedexta
J&J recalls infant Tylenol over dosing system flaw
Reuters
Friday, February 17, 2012 - 9:01am
tags:
Tylenol, recalls, JNJ
Abbott Laboratories: An Attractively Valued Dividend Aristocrat
Seeking Alpha
Friday, February 17, 2012 - 9:01am
tags:
Abbott Laboratories
5 Innovative Healthcare Companies With Histories Of Strong Growth
Seeking Alpha
Friday, February 17, 2012 - 9:00am
tags:
Abbott Laboratories, Novartis, JNJ, Allergan, Amgen
J&J’s Risperdal Wasn’t Factor in Man’s Diabetes, Jury Rules
Bloomberg
Thursday, February 16, 2012 - 5:24pm
tags:
diabetes, JNJ, Risperdal
[video] Idenix Pharmaceuticals Is Looking For Partners
TheStreet.com
Thursday, February 16, 2012 - 5:23pm
tags:
Indenix, M&A
Acorda 4Q profit climbs; company buying Neuronex
Yahoo/AP
Thursday, February 16, 2012 - 5:23pm
tags:
Neuronex, M&A, earnings, Acorda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.